Compare FMC Corp (FMC) vs Vertiv Holdings Co (VRT) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Vertiv Holdings Co. (VRT) trades at $289.06, down 4.78% over the past 24 hours, with technical indicators signaling a bearish short-term trend. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.17 surpassing the $1.00 estimate. Revenue reached $10.23 billion in 2025, with net income of $1.33 billion, while analyst consensus remains overwhelmingly bullish with a $404.33 price target. Recent news highlights Vertiv's exposure to AI data center infrastructure growth, including a $15 billion order backlog.

The outlook for VRT is positive due to robust AI-driven demand for data center power and cooling solutions, supported by a high analyst buy rating of 94.74%. Key risks include elevated valuation multiples (P/E of 76.53) and competitive pressures in the infrastructure sector. Investors should monitor execution on the large backlog and Q2 2026 earnings release on July 29, 2026, for confirmation of growth trajectory.